MA vs MTNB · P/E 38, rev $32.79B vs rev $1.1M
Mastercard Inc (MA) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
MA currently screens at market cap $515.12B and trailing P/E 38.4. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the MA and MTNB stock pages for the full models.
Not investment advice.